Jeffrey Cummings is directing one of the few early-stage studies underway on an Alzheimer’s therapy. And now that he’s scanned the records of clinicaltrials.gov, he’s acutely aware of just how small his chosen field is.

…read more

Source: Alzheimer’s R&D suffers as trial failure rate hits an ‘astounding’ 99.6%


0 No comments